Oncology News Round-Up: Cancer in Solid Organ Recipients, and More

Each week on DocWire News, editors bring you the latest in oncology news and cancer research. In case you missed it, here are this week’s top headlines:

• Cancer Linked to Shortened Life Span for Solid Organ Recipients
• Race Alone Does Not Explain Disparities in Cancer Screening
• ACS: Attitudes Toward CRC Screening Changed During Pandemic
• ASTRO: EBRT Underused in Liver Cancer Patients Awaiting Transplant

Keep reading for the breakdown on these top stories.

RELATED: Last Week’s Oncology News Round-Up: Cannabis Use in Cancer Patients

Cancer Linked to Shortened Life Span for Solid Organ Recipients

For solid organ transplant recipients, cancer is associated with a shortened life span, according to a study published in Cancer.

Researchers used linked transplant and cancer registry data to identify incident cancers and deaths among solid organ transplant recipients in the United States from 1987 to 2014. The researchers found that 5.9% of the 221,962 transplant recipients developed cancer within 10 years of transplantation.

The mean life-years lost (LYL) due to cancer were 0.16 years per transplant recipient and 2.7 years per cancer case during this period. In this population, cancer was responsible for a loss of 1.9 percent of the total life-years expected in the absence of cancer. The highest proportion of LYL due to cancer was seen in lung recipients followed by heart recipients (0.45% and 0.29%, respectively).

With age, there was an increase observed in LYL due to cancer, from 0.5 to 3.2 percent among those aged birth to 34 years at transplant and aged 50 years or older, respectively. Lung cancer was the largest contributor overall, followed by non-Hodgkin lymphoma, accounting for 24% and 15% of all LYL due to cancer, respectively.

https://www.docwirenews.com/docwire-pick/hem-onc-picks/cancer-linked-to-shortened-life-span-for-solid-organ-recipients/

Race Alone Does Not Explain Disparities in Cancer Screening

Race alone does not explain disparities in cancer screening among women, according to a study presented at the annual meeting of the North American Menopause Society.

Researchers interviewed 866 women (mean age, 43.5 years; 12% White, 36% Black, and 49% Hispanic) from underserved areas of Chicago. They found that of the women older than 50 years, only 58% were up to date on colon cancer screening, with Black women, Hispanic women, and women of other races/ethnicities less likely to have up-to-date screening versus White women. This association was not significant in an adjusted analysis.

Eight in 10 women aged 50 to 75 years reported having received a mammogram within the previous two years, with no significant association observed by race. However, Black women were more likely to have received a mammogram versus White women. For cervical cancer screening, 83% of women aged 21 to 65 years reported having cervical cancer screening in the previous five years, with no differences observed by race. Other factors associated with up-to-date cancer screenings included physical disability, diabetes diagnosis, higher trust in health care practitioners, and health insurance.

https://www.docwirenews.com/urban-health-today/urban-health-picks/race-alone-does-not-explain-disparities-in-cancer-screening/

ASTRO: EBRT Underused in Liver Cancer Patients Awaiting Transplant

ACS: Attitudes Toward CRC Screening Changed During Pandemic